Eli Lilly cuts Zepbound price to widen access for obesity drug
Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for
December 01, 2025
Virginia voters divided on new map that could help Dems flip 4 House seats
America Movil posts Q1 profit up 25%
South32 trims Australia manganese outlook after wet season, cyclone impact
Victor Wembanyama exits to be examined for concussion after falling face-first to court
Vodafone offers small businesses cybersecurity, AI capability with Google tie-up
Trump renews his call for Congress to intervene and pass legislation to control college sports
Shooting of tourists at Mexican pyramids shakes country weeks ahead of World Cup